Vimab Group AB (OSTO:VIMAB) Cyclically Adjusted Revenue per Share: kr64.77 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:VIMAB Vimab Group AB OSTO:VIMAB
52 GF Score
Price kr3.38
GF Value kr5.98
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Vimab Group AB Cyclically Adjusted Revenue per Share?

Vimab Group AB OSTO:VIMAB +2.42% 52 Cyclically Adjusted Revenue per Share is kr64.77 as of Mar. 2026. GuruFocus rates OSTO:VIMAB with a GF Score™ of 52/100 and a GF Value™ of kr5.98 (Possible Value Trap). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Vimab Group AB's adjusted revenue per share for the three months ended in Mar. 2026 was kr1.556. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is kr64.77 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Vimab Group AB's average Cyclically Adjusted Revenue Growth Rate was -8.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-07-24), Vimab Group AB's current stock price is kr3.38. Vimab Group AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was kr64.77. Vimab Group AB's Cyclically Adjusted PS Ratio of today is 0.05.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Vimab Group AB was 0.21. The lowest was 0.03. And the median was 0.11.


Vimab Group AB  (OSTO:VIMAB) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Vimab Group AB's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=3.38/64.77
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Vimab Group AB was 0.21. The lowest was 0.03. And the median was 0.11.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Vimab Group AB Cyclically Adjusted Revenue per Share Related Terms


Vimab Group AB Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Vimab Group AB's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vimab Group AB Cyclically Adjusted Revenue per Share Chart

Vimab Group AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 77.88 72.85 66.51

Vimab Group AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 71.11 69.69 68.57 66.51 64.77

OSTO:VIMAB vs VRSK, EFX, BAH: Cyclically Adjusted Revenue per Share Comparison

For the Consulting Services subindustry, Vimab Group AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vimab Group AB Cyclically Adjusted PS Ratio vs Business Services Industry

For the Business Services industry and Industrials sector, Vimab Group AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Vimab Group AB's Cyclically Adjusted PS Ratio falls into.


OSTO:VIMAB
52GF Score
Vimab Group AB OSTO:VIMAB
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vimab Group AB Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Vimab Group AB's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1.556/133.5600*133.5600
=1.556

Current CPI (Mar. 2026) = 133.5600.

Vimab Group AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 15.580 101.019 20.599
201609 8.927 101.138 11.789
201612 14.610 102.022 19.126
201703 16.235 102.022 21.254
201706 19.297 102.752 25.083
201709 13.846 103.279 17.906
201712 24.766 103.793 31.869
201803 23.796 103.962 30.571
201806 22.156 104.875 28.216
201809 18.432 105.679 23.295
201812 28.707 105.912 36.201
201903 25.424 105.886 32.069
201906 16.454 106.742 20.588
201909 12.529 107.214 15.608
201912 19.714 107.766 24.433
202003 18.940 106.563 23.738
202006 16.851 107.498 20.936
202009 4.911 107.635 6.094
202012 37.443 108.296 46.178
202103 17.720 108.360 21.841
202106 21.818 108.928 26.752
202109 22.911 110.338 27.733
202112 18.261 112.486 21.682
202203 10.979 114.825 12.770
202206 26.038 118.384 29.376
202209 3.986 122.296 4.353
202212 3.390 126.365 3.583
202303 2.004 127.042 2.107
202306 4.388 129.407 4.529
202309 4.587 130.224 4.705
202312 5.118 131.912 5.182
202403 3.006 132.205 3.037
202406 4.132 132.716 4.158
202409 3.176 132.304 3.206
202412 3.585 132.987 3.600
202503 2.186 132.825 2.198
202506 2.994 133.699 2.991
202509 3.540 133.480 3.542
202512 3.261 133.390 3.265
202603 1.556 133.560 1.556

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of kr64.77 mean?
Vimab Group AB (OSTO:VIMAB) has a Cyclically Adjusted Revenue per Share of kr64.77 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Vimab Group AB and its competitors.
Is Vimab Group AB's Cyclically Adjusted Revenue per Share too high?
Vimab Group AB's current Cyclically Adjusted Revenue per Share is kr64.77. Overall, Vimab Group AB has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Vimab Group AB's Cyclically Adjusted Revenue per Share compare to VRSK and EFX?
Vimab Group AB's Cyclically Adjusted Revenue per Share of kr64.77 can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Business Services company?
A good Cyclically Adjusted Revenue per Share depends on the Business Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Vimab Group AB and its competitors. Vimab Group AB's current Cyclically Adjusted Revenue per Share is kr64.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vimab Group AB stock overvalued right now?
Based on GuruFocus' analysis, Vimab Group AB (OSTO:VIMAB) is currently considered Possible Value Trap. The stock's GF Value™ is kr5.98, compared to a current price of kr3.38 — trading 43.5% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is kr64.77. Vimab Group AB's overall GF Score™ is 52/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Vimab Group AB (OSTO:VIMAB), the current Cyclically Adjusted Revenue per Share is kr64.77 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vimab Group AB (OSTO:VIMAB) Overvalued in 2026?

Based on GuruFocus' analysis, Vimab Group AB stock appears to be undervalued. The current stock price of kr3.38 is trading 43.5% below its estimated GF Value™ of kr5.98. GuruFocus considers Vimab Group AB to be Possible Value Trap.

Key valuation signals for OSTO:VIMAB:

  • Cyclically Adjusted Revenue per Share: kr64.77
  • GF Value™: kr5.98 vs. price of kr3.38 (43.5% below fair value)
  • GF Score™: 52/100 with 5 warning signs

No single metric tells the full story. See the OSTO:VIMAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vimab Group AB Business Description

Address Malmskillnadsgatan 40A, Stockholm, SWE, 111 57
Vimab Group AB is a Nordic company helping companies with transformation and improvement initiatives. It offers services including Interim management, Executive search.
52GF Score

Get the complete analysis for OSTO:VIMAB

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr3.38
Price
kr5.98
GF Value